IHI vs XAR: Holdings Overlap & Returns
Over the year to Nov 13, 2026, IHI returned −7.4% to XAR's +1.7%; 0% of their weight is in the same names.
- Return gap
- +9.1 pts1 year to Nov 13, 2026: XAR ahead, total return
- Fee gap
- 0.02 ptsA year: IHI 0.37%, XAR 0.35%, per filings dated Jul 27, 2026 and Nov 3, 2026
- Overlap
- 0%Share of the two books held in common, holdings dated Nov 12, 2026
- Net flow
- +$76m / −$395mIHI / XAR, Oct 13, 2026 to Nov 12, 2026, daily basis
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
IHI −7.4%, XAR +1.7%: XAR +9.1 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in IHI costs about $1.00 one way and $2.00 in and out, at a median spread of 0.02%. The 0.02% spread is IHI’s 30-day median, from iShares (fund page).
Fees over time
Hypothetical. $10,000 in IHI for 10 years at 0.37% a year costs about $615 in fees and lost growth; XAR at 0.35% would cost $583. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
89% of IHI's weight is in S&P 500 companies and 12% is outside the index. Holdings as of Nov 12, 2026.
39% of XAR's weight is in S&P 500 companies and 61% is outside the index. Holdings as of Nov 12, 2026.
Key numbers
XAR costs 0.02 points a year less; their one-year returns differ by 9.1 points; XAR is 1.3 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | −7.4% | +1.7% |
|---|---|---|
| Below its all-time high | 11.5%, high on Sep 8, 2021 | 22.2%, high on Aug 14, 2026 |
| What it tracks | Therapeutics and medical devices | Defense |
| Against the S&P 500, 1 year | behind by 11.8 pts | |
| Its benchmark, total return, 1 year | +13.5% | |
| Against its benchmark, 1 year | behind by 11.8 pts | |
| Expense ratio | 0.37% | 0.35% |
| Net assets, as of Nov 12, 2026 | $4.0bn | $5.1bn |
| Holdings in common | 0% |
The numbers behind it
Net assets: $4.1bn on Nov 13, 2026 for iShares U.S. Medical Devices ETF, and $5.1bn on Nov 12, 2026 for State Street SPDR S&P Aerospace & Defense ETF.
Holdings in common uses holdings dated Nov 12, 2026.
What they share
By the books each fund has filed, IHI and XAR hold 0% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026.
half
0% in common
Only in IHI
Show all 8 holdings
| ABBOTT LABORATORIES | 17.27% |
| INTUITIVE SURGICAL | 14.46% |
| MEDTRONIC PLC | 11.51% |
| IDEXX LABORATORIES | 5.48% |
| EDWARDS LIFESCIENCES | 4.96% |
| BECTON DICKINSON AND CO | 4.85% |
| GE HEALTHCARE TECHNOLOGIES | 4.63% |
| STRYKER | 4.59% |
Only in XAR
Show all 8 holdings
| LOCKHEED MARTIN CORP | 3.44% |
| HUNTINGTON INGALLS INDUSTRIE | 3.28% |
| HONEYWELL AEROSPACE INC | 3.26% |
| HEICO CORP | 3.24% |
| L3HARRIS TECHNOLOGIES INC | 3.24% |
| STANDARDAERO INC | 3.22% |
| TRANSDIGM GROUP INC | 3.19% |
| NORTHROP GRUMMAN CORP | 3.18% |
Side by side
Open the table
| Fund | iShares U.S. Medical Devices ETF · Holds 51 stocks in therapeutics and medical devices, 88% of its weight in S&P 500 companies | State Street SPDR S&P Aerospace & Defense ETF · Holds 50 stocks in defense, 39% of its weight in S&P 500 companies |
| Issuer | iShares | State Street |
| Theme | Therapeutics and medical devices | Defense |
| In the S&P 500 | 88.5% | 39.0% |
| Active share vs the S&P 500 | 98.7% | 97.7% |
| In the Nasdaq-100 | 28.4% | 8.2% |
| Holdings | 51 | 50 |
| Top ten, share of the fund | 76.0% | 32.3% |
| Expense ratio | 0.37% | 0.35% |
| Fee for the differing part | 0.37% | 0.36% |
| Total return, 1 year | −7.4% | +1.7% |
| vs its benchmark | not measured | −11.8 pts vs VOO |
| Below its high | −11.5% | −22.2% |
| Net assets, IHI as of Nov 13, 2026 and XAR as of Nov 12, 2026 | $4.1bn | $5.1bn |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +4.2% | −22.2% | not measured | −19.6 pts vs VOO |
|---|---|---|---|---|
| 6 months | +20.1% | −11.5% | not measured | −14.1 pts vs VOO |
| 1 year | −7.4% | +1.7% | not measured | −11.8 pts vs VOO |
| 3 years | +23.4% | +86.8% | not measured | +12.1 pts vs VOO |
| Since launch (Not the same days: IHI May 2006 · XAR Sep 2011) | +658.0% | +971.9% | not measured | +218.8 pts vs VOO |
From Oct 2011 to Nov 2026, XAR returned more: +965.2% to +562.7%. IHI swung less: 18.0% to 23.3%. IHI fell less at its worst: −32.7% to −45.1%.
Full scorecard
Open the table
| Total return | +562.7% | +965.2% | XAR | Price change plus distributions, reinvested. |
| Annualized | +13.3% | +16.9% | XAR | Total return as a yearly rate. |
| Price return | +515.4% | +811.1% | XAR | Price change alone, distributions left out. |
| Volatility | 18.0% | 23.3% | IHI | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 12.3% | 15.5% | IHI | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −32.7% | −45.1% | IHI | Deepest fall from a high to the low after it. |
| Sharpe | 0.69 | 0.72 | XAR (slight) | Return above Treasury bills per unit of volatility. |
| Sortino | 1.01 | 1.07 | XAR (slight) | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.41 | 0.37 | IHI (slight) | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 788 weekly returns. Cash rate: the 13-week Treasury bill.
About IHI
By weight, 88% of IHI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 76% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned −7.4% with distributions reinvested. It sits 11.5% below its all-time high of Sep 8, 2021.
About XAR
By weight, 39% of XAR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 32% of the fund across 50 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +1.7% with distributions reinvested against +13.5% for its benchmark, the S&P 500 Index, so a holder was behind by 11.8 pts. It sits 22.2% below its all-time high of Aug 14, 2026.
0% of the two portfolios are the same securities at the same weight.
Questions people ask
Do IHI and XAR hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, IHI against XAR, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ihi-vs-xar
ETFIQ. (Nov 13, 2026). IHI against XAR. Retrieved from https://etfiq.com/compare/themes/ihi-vs-xar
[IHI against XAR (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ihi-vs-xar)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.